RPS24P16

Across TCGA pan-cancer cohorts, RPS24P16 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPS24P16’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS24P16 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS24P16 is over-expressed in tumor.

COAD, PRAD, and LUAD are the cancer types where RPS24P16 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS24P16 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+1.210	<.001	6	view →
PRAD	All	All	+0.110	.040	2	view →
LUAD	All	All	+0.255	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPS24P16–COAD

Open the COAD breakdown →